Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are pleased to present the latest issue of touchREVIEWS in Endocrinology, which offers a timely and thoughtprovoking collection of articles that reflect both the continuity and evolution of diabetes and metabolic disease research. In an era where technology, public health priorities and clinical paradigms are shifting rapidly, this issue highlights the importance of evidence-based […]

Search Results

Showing Results for Acromegaly

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Endocrinology, which features a range of review, case report and original research articles that highlight some key developments in our understanding and management of endocrinological disease. We begin with a commentary from ...

Mark CompleteCompleted
BookmarkBookmarked
Meliha Melin Uygur, Marta Villanova, Stefano Frara

Acromegaly is a chronic disease caused by an excess of growth hormone (GH) and insulin-like growth factor 1 (IGF-1).1,2 Besides facial and acral changes, systemic complications lead to decreased quality of life and survival rates.3 The primary goal of acromegaly treatment ...

Mark CompleteCompleted
BookmarkBookmarked
David S McLaren, Khyatisha Seejore, Julie Lynch

Acromegaly is the clinical consequence of chronic excessive exposure of the tissues to growth hormone (GH) and its second messenger, insulin-like growth factor-I (IGF-I). The excess GH secretion is almost exclusively secondary to a GH-secreting pituitary adenoma (somatotropinomas); however, excess ...

Mark CompleteCompleted
BookmarkBookmarked

Clinicians depend on accurate, precise and reproducible hormone measurements for the diagnosis and management of endocrine disorders. Immunoassays have constituted one of the major methods of measuring hormone levels in blood, urine and other fluids, as well as in tissue ...

Mark CompleteCompleted
BookmarkBookmarked
Mandeep Singla, Jaspreet Kaur Saini

Acromegaly is a chronic, progressive disease characterized by an excess secretion of growth hormone, and consequently, increased circulating insulin-like growth factor 1 (IGF-1) levels. These patients typically exhibit acral and soft tissue overgrowth, headache, arthritis and visual disturbances. Impaired glucose tolerance ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest issue of the newly-renamed touchREVIEWS in Endocrinology, previously European Endocrinology. The decision to rename and widen the reach of the journal has been taken after a great year for touchENDOCRINOLOGY, and we feel that in an ...

Mark CompleteCompleted
BookmarkBookmarked
Martin J Rutkowski, Derek G Southwell, Tyler M Cardinal

McCune–Albright syndrome (MAS) is a genetic disorder first described by McCune1 and Albright2  in the 1930s as a triad of polyostotic fibrous dysplasia, café-au-lait spots, and precocious puberty (Figure 1). Since then, other hyperfunctioning endocrinopathies have been described in ...

Mark CompleteCompleted
BookmarkBookmarked

Welcome to the summer edition of US Endocrinology. In this issue we present authoritative, up-to-date information on a wide range of salient topics. The pandemic of obesity is driving the diabetes epidemic across the globe, with developing countries especially bearing ...

Mark CompleteCompleted
BookmarkBookmarked

The pituitary gland, or hypophysis, is the ‘master gland’ that secretes multiple hormones which regulate the functioning of other endocrine organs, such as the thyroid, adrenal cortex and gonads. Though none of the major pituitary hormones directly control the endocrine ...

Mark CompleteCompleted
BookmarkBookmarked

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant endocrine tumour syndrome characterised by three main manifestations which are primary hyperparathyroidism (78–94%), gastroenteropancreatic neuroendocrine tumours (GEP-NETs) (35–78%) and pituitary adenomas (20–65%).1 As described, GEP-NETs are the second most common component of MEN1 syndrome ...

Mark CompleteCompleted
BookmarkBookmarked

Pituitary adenomas are benign tumours that arise from the adenohypophysis. They are the second most frequent intracranial tumour type after meningiomas, and account for 16.2% of all primary cranial neoplasms.1 Though likely an underestimate, the incidence of pituitary adenomas is approximately ...

Mark CompleteCompleted
BookmarkBookmarked

  Welcome to the latest edition of European Endocrinology, which features a range of articles describing current practices and research that directly affect endocrinologists, as well as being of interest to the wider biomedical community. Diabetes is the focus of ...

Mark CompleteCompleted
BookmarkBookmarked

Acromegaly is a chronic disorder characterised by growth hormone (GH) hypersecretion, predominantly caused by a pituitary adenoma.1 Disease prevalence ranges from 2.8–13.7 cases and annual incidence is between 0.2–1.1 cases/100,000 people; however, real incidence is likely much higher.2,3 Average age at diagnosis ...

Mark CompleteCompleted
BookmarkBookmarked

Growth/growth hormone/insulin-like growth factors Evidence has long supported insulin-like growth factor-2 (IGF-2) as an important fetal growth factor. Begemann and co-workers from Germany and the Netherlands report four patients from a multigenerational family with the combination of severe ...

Mark CompleteCompleted
BookmarkBookmarked

Acromegaly is an uncommon disorder that, in the vast majority of cases, is the result of a growth hormone (GH)-secreting pituitary adenoma. Because tumors are often macroadenomas at the time of diagnosis, there may be a number of signs ...

Load More...
Close Popup